Dubuquoy, Laurent, 1975-....
![Sudoc [ABES], France](/viaf/images/flags/SUDOC.png "Sudoc [ABES], France")
Laurent Dubuquoy researcher
VIAF ID: 208099032 (Personal)
Permalink: http://viaf.org/viaf/208099032
Preferred Forms
4xx's: Alternate Name Forms (1)
Works
| Title | Sources |
|---|---|
| [30] INVOLVEMENT OF NOD SIGNALLING IN HEPATOCYTE AND IMMUNE CELLS DURING HEPATITIS |
|
| The 5-aminosalicylic acid antineoplastic effect in the intestine is mediated by PPARγ. |
|
| 979 Modulating Peroxisome Proliferator-Activated Receptor Gamma (PPARγ): A Potential New Therapeutic Strategy for Lactose Intolerance |
|
| Atypical cadherin MUCDHL and inflammatory bowel diseases : involvement in pathogeny, evolution and response to treatment. |
|
| Caracterization of the nuclear receptor FXRα in germ cell tumours and functional study of a new variant. |
|
| Cholesterol-enriched membrane microdomains are needed for insulin signaling and proliferation in hepatic cells. |
|
| Colonic inflammation in mice is improved by cigarette smoke through iNKT cells recruitment |
|
| Conception et synthèse de purines substituées en positions C8 et N9 en tant qu'antagonistes potentiels du récepteur NOD1 en vue de limiter les lésions d'ischémie-reperfusion hépatique |
|
| Contribution of the Gut Microbiota in P28GST-Mediated Anti-Inflammatory Effects: Experimental and Clinical Insights |
|
| Controlled delivery of a new broad spectrum antibacterial agent against colitis: In vitro and in vivo performance |
|
| Ductular Reaction Cells Display an Inflammatory Profile and Recruit Neutrophils in Alcoholic Hepatitis |
|
| Enteric Delivery of Regenerating Family Member 3 alpha Alters the Intestinal Microbiota and Controls Inflammation in Mice With Colitis |
|
| Escherichia coli LF82 differentially regulates ROS production and mucin expression in intestinal epithelial T84 cells: implication of NOX1. |
|
| Etude de la délivrance d'antigènes dans les voies aériennes en utilisant des nanoparticules de maltodextrine lipidées |
|
| Etude du rôle du récepteur nucléaire FXRα dans la physiologie et la physiopathologie testiculaire |
|
| The Expression of the Short Isoform of Thymic Stromal Lymphopoietin in the Colon Is Regulated by the Nuclear Receptor Peroxisome Proliferator Activated Receptor-Gamma and Is Impaired during Ulcerative Colitis |
|
| High carriage of adherent invasive E. coli in wildlife and healthy individuals. |
|
| Impact of supra physiological concentrations of bile acids on male reproductive functions and transgenerational inheritance. |
|
| Impacts de concentrations supraphysiologiques d'acides biliaires sur la physiologie testiculaire et les fonctions de reproduction |
|
| Implication of TNF-Related Apoptosis-Inducing Ligand in Inflammatory Intestinal Epithelial Lesions |
|
| In vivo efficacy of microbiota-sensitive coatings for colon targeting: a promising tool for IBD therapy |
|
| In vivo imaging reveals selective PPAR activity in the skin of peroxisome proliferator-activated receptor responsive element-luciferase reporter mice |
|
| Increased lymphatic vessel density and lymphangiogenesis in inflammatory bowel disease. |
|
| Intestinal fibrosis, mineralocorticoid receptor, diet. |
|
| Intestinal steroidogenesis |
|
| Lactobacillus acidophilus modulates intestinal pain and induces opioid and cannabinoid receptors |
|
| Liver receptor homolog 1 contributes to intestinal tumor formation through effects on cell cycle and inflammation |
|
| LRH-1-mediated glucocorticoid synthesis in enterocytes protects against inflammatory bowel disease |
|
| Luteolin prevents irinotecan-induced intestinal mucositis in mice through antioxidant and anti-inflammatory properties |
|
| Lymphoid Aggregates Remodel Lymphatic Collecting Vessels that Serve Mesenteric Lymph Nodes in Crohn Disease |
|
| Mécanismes de l'inflammation hépatique liée à l'obésité |
|
| Mécanismes vasculaires et thrombotiques dans les maladies inflammatoires chroniques de l'intestin |
|
| Mesenteric fat as a source of C reactive protein and as a target for bacterial translocation in Crohn's disease |
|
| MicroRNA in alcoholic hepatitis: implications for pathophysiology and treatment. |
|
| Modeling the inflammatory response dynamics following tissue damage in adult mammals. |
|
| Modélisation de la dynamique de la réponse inflammatoire suite à un dommage tissulaire chez le mammifère adulte |
|
| Modulation of intestinal inflammation by yeasts and cell wall extracts: strain dependence and unexpected anti-inflammatory role of glucan fractions |
|
| Murine model of dextran sulfate sodium-induced colitis reveals Candida glabrata virulence and contribution of β-mannosyltransferases |
|
| Neoboutonia melleri var velutina Prain: in vitro and in vivo hepatoprotective effects of the aqueous stem bark extract on acute hepatitis models |
|
| No Evidence for an Involvement of the P38 and JNK Mitogen-Activated Protein in Inflammatory Bowel Diseases |
|
| NOD2: a potential target for regulating liver injury |
|
| Novel PPARγ Modulator GED-0507-34 Levo Ameliorates Inflammation-driven Intestinal Fibrosis |
|
| The nuclear receptor LRH-1 critically regulates extra-adrenal glucocorticoid synthesis in the intestine |
|
| [Nuclear receptor PPAR and hepatology: pathophysiological and therapeutical aspects]. |
|
| Nucleotide-binding oligomerization domain 1 (NOD1) modulates liver ischemia reperfusion through the expression adhesion molecules |
|
| Obesity, visceral fat and Crohn's disease |
|
| One- or Two-Step Synthesis of C-8 and N-9 Substituted Purines |
|
| Optimisation de la prise en charge de la rectocolite hémorragique : de la théorie à la pratique |
|
| Optimization of maltodextrin based nanoparticles with lipid core for vaccine purposes. |
|
| P084 Dissecting the role of PPARgamma in intestinal fibrosis: EMT-activator ZEB1 as new molecular target |
|
| Periodontal manifestations of inflammatory bowel disease: emerging epidemiologic and biologic evidence |
|
| Perméabilité intestinale et régulation de l'expression du gène CEACAM6 : implication des bactéries Escherichia coli associées à la maladie de Crohn |
|
| Polymorphisms in the Mannose-Binding Lectin Gene are Associated with Defective Mannose-Binding Lectin Functional Activity in Crohn's Disease Patients |
|
| PPAR-gamma in ulcerative colitis: a novel target for intervention |
|
| PPARgamma as a new therapeutic target in inflammatory bowel diseases |
|
| PPARγ agonists as a new class of effective treatment for ulcerative colitis |
|
| Prise en charge chirurgicale de l'obèse et de l'obèse morbide : conséquences sur la stéatopathie métabolique et sur l'accès à la transplantation hépatique |
|
| Progenitor cell expansion and impaired hepatocyte regeneration in explanted livers from alcoholic hepatitis |
|
| Resistin-like molecule beta regulates intestinal mucous secretion and curtails TNBS-induced colitis in mice |
|
| Rôle de l'hétérodimère récepteur activé par les proliférateurs de peroxysomes gamma (PPARγ) / récepteur X des rétinoi͏̈des (RXR) au cours de l'inflammation intestinale |
|
| Rôle des opioïdes d'origine immunitaire dans la physiologie intestinale |
|
| Role of mannose-binding lectin in intestinal homeostasis and fungal elimination |
|
| Role of peroxisome proliferator-activated receptor gamma and retinoid X receptor heterodimer in hepatogastroenterological diseases |
|
| Role of TLR1, TLR2 and TLR6 in the modulation of intestinal inflammation and Candida albicans elimination |
|
| Scaffold attachment factor B1 directly interacts with nuclear receptors in living cells and represses transcriptional activity |
|
| Short fungal fractions of β-1,3 glucans affect platelet activation. |
|
| Starch nanoparticles improve curcumin-induced production of anti-inflammatory cytokines in intestinal epithelial cells |
|
| Study of the airway antigen delivery using lipidated maltodextrin nanopoarticles. |
|
| Study of the potentiation of curcumin by nanoparticles to treat chronic inflammatory bowel diseases. |
|
| Surgical management of obese and morbid obese : consequences on non-alcoholic fatty liver disease and on access to liver transplantation. |
|
| Therapeutic optimization during ulcerative colitis : from bench to clinic. |
|
| Treatment with P28GST, a schistosome-derived enzyme, after acute colitis induction in mice: Decrease of intestinal inflammation associated with a down regulation of Th1/Th17 responses |
|
| Tu1881 HLA B27 Transgenic Rat: A New Animal Model of Postsurgical Ileitis in Inflammatory Bowel Disease |
|
| Variants of NOD1 and NOD2 genes display opposite associations with familial risk of Crohn's disease and anti-saccharomyces cerevisiae antibody levels. |
|
| Vascular and thrombotic mechanisms in chronic inflammatory bowel disease. |
|
| Visceral fat and gut inflammation |
|
| Yersinia pseudotuberculosis anti-inflammatory components reduce trinitrobenzene sulfonic acid-induced colitis in the mouse |
|
| β-Hydroxybutyrate protects from alcohol-induced liver injury via a Hcar2-cAMP dependent pathway |
|
